MET-targeting antibody (emibetuzumab) and kinase inhibitor...

  • Main
  • 2017 / 11
  • MET-targeting antibody (emibetuzumab) and kinase inhibitor...

MET-targeting antibody (emibetuzumab) and kinase inhibitor (merestinib) as single agent or in combination in a cancer model bearing MET exon 14 skipping

Yan, S. Betty, Um, Suzane L., Peek, Victoria L., Stephens, Jennifer R., Zeng, Wei, Konicek, Bruce W., Liu, Ling, Manro, Jason R., Wacheck, Volker, Walgren, Richard A.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
Investigational New Drugs
DOI:
10.1007/s10637-017-0545-x
Date:
November, 2017
File:
PDF, 1.58 MB
english, 2017
Conversion to is in progress
Conversion to is failed